Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Lee

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|May 31, 2021
We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver DiseasesBrian T Lee, Michele M Tana, Jeffrey A Kahn, et al.
Transplantation Direct|May 17, 2024
Differential Effects of Ascites and Hepatic Encephalopathy on Waitlist Mortality in Liver Transplantation by MELD 3.0Brian T Lee, Nathan T Chen, Tse-Ling Fong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 14, 2019
Checkpoint Inhibitor-Induced Rejection of a Liver Allograft: A Combination of Acute T Cell-Mediated and Antibody-Mediated RejectionBrian T Lee, Brian H Horwich, Shefali Chopra, et al.
Clinical Transplantation|December 6, 2025
Comparison of Kidney Allograft Outcomes in Simultaneous Liver-Kidney Versus Kidney After Liver Transplantation Since the Safety Net EraBrian T Lee, Jennifer L Dodge, Santhi Voora, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2010
Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005-2006 national surveyDusko Vulic, Brian T Lee, Jennifer Dede, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 8, 2021
Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patientsBrian T Lee, Mimi Chang, Carolina Lim, et al.
Gastroenterology|May 23, 2020
COVID-19 in Liver Transplant Recipients: An Initial Experience From the US EpicenterBrian T Lee, Ponni V Perumalswami, Gene Y Im, et al.
Journal of Viral Hepatitis|December 22, 2018
Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamideTse-Ling Fong, Brian T Lee, Andy Tien, et al.
Archives of Medical Science : AMS|February 29, 2012
Risk factor control and adherence to treatment in patients with coronary heart disease in the Republic of Srpska, Bosnia and Herzegovina in 2005-2006Dusko Vulic, Sasa Loncar, Milenko Krneta, et al.
Clinical Case Reports|July 31, 2019
A rare systemic etiology of heart failure and liver dysfunctionChristopher Lee, Edward Chau, Sumit Patel, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|May 31, 2021
We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver DiseasesBrian T Lee, Michele M Tana, Jeffrey A Kahn, et al.
Transplantation Direct|May 17, 2024
Differential Effects of Ascites and Hepatic Encephalopathy on Waitlist Mortality in Liver Transplantation by MELD 3.0Brian T Lee, Nathan T Chen, Tse-Ling Fong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 14, 2019
Checkpoint Inhibitor-Induced Rejection of a Liver Allograft: A Combination of Acute T Cell-Mediated and Antibody-Mediated RejectionBrian T Lee, Brian H Horwich, Shefali Chopra, et al.
Clinical Transplantation|December 6, 2025
Comparison of Kidney Allograft Outcomes in Simultaneous Liver-Kidney Versus Kidney After Liver Transplantation Since the Safety Net EraBrian T Lee, Jennifer L Dodge, Santhi Voora, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2010
Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005-2006 national surveyDusko Vulic, Brian T Lee, Jennifer Dede, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 8, 2021
Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patientsBrian T Lee, Mimi Chang, Carolina Lim, et al.
Gastroenterology|May 23, 2020
COVID-19 in Liver Transplant Recipients: An Initial Experience From the US EpicenterBrian T Lee, Ponni V Perumalswami, Gene Y Im, et al.
Journal of Viral Hepatitis|December 22, 2018
Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamideTse-Ling Fong, Brian T Lee, Andy Tien, et al.
Archives of Medical Science : AMS|February 29, 2012
Risk factor control and adherence to treatment in patients with coronary heart disease in the Republic of Srpska, Bosnia and Herzegovina in 2005-2006Dusko Vulic, Sasa Loncar, Milenko Krneta, et al.
Clinical Case Reports|July 31, 2019
A rare systemic etiology of heart failure and liver dysfunctionChristopher Lee, Edward Chau, Sumit Patel, et al.
Pageof 6